PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>−</sup> subset
AID  - 10.1136/jitc-2021-003385corr1
DP  - 2022 Mar 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003385corr1
VI  - 10
IP  - 3
4099  - http://jitc.bmj.com/content/10/3/e003385corr1.short
4100  - http://jitc.bmj.com/content/10/3/e003385corr1.full
SO  - J Immunother Cancer2022 Mar 01; 10